Adam Koppel, Director, 10% Owner at Cerevel Therapeutics Holdings, Inc. (CERE), bought 10,960,104 shares at $22.81 ($250.0M) on 2023-10-16, disclosed to the SEC on 2023-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.81 | 5,480,052 | $125.0M | 50.0% |
| 2 | $22.81 | 5,480,052 | $125.0M | 50.0% |
| Total | $22.81 avg | 10,960,104 | $250.0M | 100% |
| Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-11-12 | $6.8M | — | Filing → |
| CERE | BUY | 2020-10-29 | $100.0M | — | Filing → |